ERBB2 and congenital rubella syndrome: HER2-XPAT protein showed minimal toxicity at a dose ≤42 mg kg−1 (defined as the MTD, single dose), with severe toxicity (unrelated to cytokine release syndrome (CRS)) evident at 50 mg kg−1 (Fig. 5a).